American Society Of Clinical Oncology

This study is testing whether starting older patients (age 65+) with advanced breast cancer on lower doses of two common oral cancer drugs helps them stay on treatment longer. Participants will be randomly assigned to either take the standard full dose or start with a lower dose …

This study aims to learn from real-world experience by observing how well FDA-approved targeted cancer drugs work for patients with advanced solid tumors, lymphoma, or multiple myeloma. It enrolls over 4,000 patients whose tumors have specific genetic changes that suggest a drug …